Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Filter By:

Search by Keyword (disease, investigator, treatment name):

Managed Access Program (MAP) to provide alpelisib (BYL719) for patients with PIK3CA-Related Overgrowth Spectrum (PROS)

Pediatrics

Disease Sites: Pediatrics

Phase: N/A

Investigator: Zarnegar-Lumley, Sara

NCTID: NCT04085653

Protocol No: VICCPED1985

Clinical Trial Flowcharts
for Referring Physicians

Clinical Trial Flowcharts
for VICC Staff (VUNetID required)